We operate a customer-centric approach; our customers are at the heart of our thinking process to provide the most appropriate solutions
Competitive Intelligence & Strategic Intelligence for the Life Science Industry
We support Life Sciences Clients in developing and marketing innovative patient treatments globally, through Strategic intelligence.
Whether a small biotech or a large pharmaceutical company, understanding your market environment is paramount for a differentiating strategy & greater ROI.
Your market intelligence and competitive intelligence services UNIQUELY based on high value added sources for secondary analysis and validation from primary research.
At GlobalReach Business Solutions, we aim to help our customers, of ALL sizes, within the Life Science industry (biotech, pharma, consumer health, medical devices), improve treatments and care for patients globally.
The life science industry is faced with major pressure to reduce costs, improve efficiency and provide value to patients. Fortunately, opportunities and long-term growth, with precision medicine for example, provide a positive outlook to the future.
In the current global economy, companies have to be able to seize the new market opportunities, as well as being aware of the growing competition. In this fierce competitive environment, the most essential tool for any company is Intelligence.
Our vision is to support your vision.
In our daily operations and our decision-making process, we follow fundamental values
GlobalReach Business Solutions is structured into 2 business segments:
- Business Intelligence: the objective is to support our clients improve treatments and care for patients globally, with appropriate Business Intelligence with the aim of generating insights to:
- Facilitate R&D Project Optimization (understanding scientific & competitive landscape)
- Support funding series for appropriate investment
- Identify and validate best partners for short term ROI (deal prioritization)
- International Business Development: the objective is to support our clients with the implementation of an international business development strategy and the increase of your market share worldwide:
- Facilitate market access
- Establish the best market launch strategy
- Support due diligence
SEEN ON TV
BIO2016 San Francisco
TV interview of Yamina Hakem CEO, GlobalReach Business Solutions, on how we support the biotech industry innovation and partnering, in June 2016 during BIO Conference in San Francisco. Please note discussion is in French.
See What Our Customers Have to Say About Us
Yamina has very strong professional skills. She developed and run a tailored seminar on Competitive Intelligence per our specific purposes. This seminar set up the ground for enhancing this new organizational capability within UPSA organization. Yamina shared her knowledge and know-how with energy and passion. She demonstrated customer-focus, agility, reliability with an entrepreneurial spirit. She balances strong interpersonal skills and a clear business mindset. Should need an expert in Competitive intelligence and a reliable partner, I strongly recommend Yamina. I wish her the best success in the new business she is currently setting up in San Francisco
I have been working for several years with Yamina Hakem. Her professionalism and her talent in developing and tailoring business solutions to specific needs are exceptional. On top of being a brilliant professional partner, Yamina is a very smart person who cares for others. I wish we pursue our collaborations in the future.
Thank you very much, Yamina Hakem for these few days in San Francisco to helping me understand the US market and developing my network in preparation for Hyprevention market entry!
Three months into the COVID-19 Pandemic, we can all reflect on how we have had to change… and fast! We are working from home, schooling our children and restricting all travel, we have had to learn and adjust rapidly to this new normal. Read more here: The “New Normal” in Life Science Coverage: SPRING Forward with […]
To reduce the cost and increase the probability of success, life sciences would seem a model industry to benefit from the implementation of artificial intelligence tools and yet as an industry we are still lagging behind others in taking advantage of advanced AI. Why?
Not a day goes by without reading about the major deception caused by the Theranos saga; promising innovative blood tests to patients based on unknown technology backed by million-dollar investments. Now, the consequences will be suffered by the rest of the Silicon Valley Biotech industry; most probably they will be the ones bearing the brunt […]